相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
Margarite D. Matossian et al.
BMC CANCER (2019)
A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer
Florence Coussy et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Rogaratinib: A potent and selective pan-FGFR inhibitor with broad antitumor activity in FGFR-overexpressing preclinical cancer models
Sylvia Gruenewald et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
D. Merino et al.
NATURE COMMUNICATIONS (2019)
Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer
Jin-Sun Ryu et al.
CANCERS (2019)
The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer
Ikbale El Ayachi et al.
CANCER RESEARCH (2019)
Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study
Shin-Ae Kang et al.
CLINICAL CANCER RESEARCH (2019)
Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells
Kana Tominaga et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
Suping Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models
Xia Liu et al.
CANCER DISCOVERY (2019)
Patient-derived xenografts: a promising resource for preclinical cancer research
Christina Karamboulas et al.
MOLECULAR & CELLULAR ONCOLOGY (2019)
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
C. Cruz et al.
ANNALS OF ONCOLOGY (2018)
Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer
Yunhui Hu et al.
CANCER LETTERS (2018)
Novel cancer gene variants and gene fusions of triple-negative breast cancers (TNBCs) reveal their molecular diversity conserved in the patient-derived xenograft (PDX) model
Jaeyun Jung et al.
CANCER LETTERS (2018)
Establishment of a Patient-Derived Tumor Xenograft Model and Application for Precision Cancer Medicine
Seiji Okada et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2018)
Pharmacological Inhibition of NOS Activates ASK1/JNK Pathway Augmenting Docetaxel-Mediated Apoptosis in Triple-Negative Breast Cancer
Daniel Davila-Gonzalez et al.
CLINICAL CANCER RESEARCH (2018)
Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling
Adrian Gonzalez-Gonzalez et al.
CLINICAL CANCER RESEARCH (2018)
Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance
Gorka Ruiz de Garibay et al.
DISEASE MODELS & MECHANISMS (2018)
Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
Minan Wang et al.
FASEB JOURNAL (2018)
Patient-Derived Xenograft Tumor Models: Overview and Relevance to IR
Rahul A. Sheth et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
In vivo reprogramming drives Kras-induced cancer development
Hirofumi Shibata et al.
NATURE COMMUNICATIONS (2018)
Activated matriptase as a target to treat breast cancer with a drug conjugate
Gulam M. Rather et al.
Oncotarget (2018)
Ultra-Sensitive HIV-1 Latency viral Outgrowth Assays Using Humanized Mice
Kimberly Schmitt et al.
FRONTIERS IN IMMUNOLOGY (2018)
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
Marta Castroviejo-Bermejo et al.
EMBO MOLECULAR MEDICINE (2018)
Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma
Christina Karamboulas et al.
CELL REPORTS (2018)
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts
Chiara Agnoletto et al.
BIOMARKER RESEARCH (2018)
IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer
Dong Wang et al.
CELL DEATH AND DIFFERENTIATION (2018)
Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model
Sreeraj G. Pillai et al.
BREAST CANCER RESEARCH (2018)
TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer
Tiara T. Byrd et al.
CANCER RESEARCH (2018)
Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models
Roberto R. Rosato et al.
BREAST CANCER RESEARCH (2018)
Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2(+) Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant
Pei-Yin Hsu et al.
CLINICAL CANCER RESEARCH (2018)
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Xian Chen et al.
CLINICAL CANCER RESEARCH (2018)
Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis
Wilhem Leconet et al.
CLINICAL CANCER RESEARCH (2017)
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition
Aditya Dutta et al.
EUROPEAN UROLOGY (2017)
Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2-and ER+HER2+) breast cancers
Noriko Kanaya et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
Matthew P. Goetz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Patient-derived xenografts as in vivo models for research in urological malignancies
Takahiro Inoue et al.
NATURE REVIEWS UROLOGY (2017)
The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer
Iram Fatima et al.
PLOS ONE (2017)
Modulation of telomere protection by the PI3K/AKT pathway
Marinela Mendez-Pertuz et al.
NATURE COMMUNICATIONS (2017)
Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness
Moro Massimo et al.
SCIENTIFIC REPORTS (2017)
Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer
Matthew P. Goetz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases
Maria J. Contreras-Zarate et al.
FRONTIERS IN ONCOLOGY (2017)
Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine
Katherine M. Morgan et al.
FRONTIERS IN ONCOLOGY (2017)
Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study
Jia Yu et al.
BREAST CANCER RESEARCH (2017)
Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer
Luigi Formisano et al.
CLINICAL CANCER RESEARCH (2017)
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors
Kurt W. Evans et al.
CLINICAL CANCER RESEARCH (2017)
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
Natalia Paez Arango et al.
BREAST CANCER RESEARCH (2017)
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Annette T. Byrne et al.
NATURE REVIEWS CANCER (2017)
Proteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts
Hua Li et al.
MOLECULAR CANCER RESEARCH (2016)
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease
Bjoern Chapuy et al.
BLOOD (2016)
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
Shom Goel et al.
CANCER CELL (2016)
Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap
J. Jason Morton et al.
CANCER RESEARCH (2016)
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
Alejandra Bruna et al.
CELL (2016)
Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis
Rachel Eyre et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2016)
Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases
Jing Ni et al.
NATURE MEDICINE (2016)
An original patient-derived xenograft of prostate cancer with cyst formation
Takeshi Yoshikawa et al.
PROSTATE (2016)
Inflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancer
Hui-Ying Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
Tumor microenvironment: Sanctuary of the devil
Lanlan Hui et al.
CANCER LETTERS (2015)
Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts
John W. Cassidy et al.
CANCER RESEARCH (2015)
GEMMs as preclinical models for testing pancreatic cancer therapies
Aarthi Gopinathan et al.
DISEASE MODELS & MECHANISMS (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Mouse hospital and co-clinical trial project-from bench to bedside
John G. Clohessy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Comparison of 2D-and 3D-culture models as drug-testing platforms in breast cancer
Yoshinori Imamura et al.
ONCOLOGY REPORTS (2015)
Patient-derived bladder cancer xenografts: a systematic review
Carina Bernardo et al.
TRANSLATIONAL RESEARCH (2015)
A co-clinical platform to accelerate cancer treatment optimization
Andrea Lunardi et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Subtyping of Triple-Negative Breast Cancer: Implications for Therapy
Vandana G. Abramson et al.
CANCER (2015)
Patient-derived xenograft models of breast cancer and their predictive power
James R. Whittle et al.
BREAST CANCER RESEARCH (2015)
Tumorgrafts as In Vivo Surrogates for Women with Ovarian Cancer
S. John Weroha et al.
CLINICAL CANCER RESEARCH (2014)
Generation of improved humanized mouse models for human infectious diseases
Michael A. Brehm et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
Cancer mouse models: Past, present and future
Walid T. Khaled et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition
Haiyu Zhang et al.
BREAST CANCER RESEARCH (2014)
Triple-Negative Breast Cancer and the Need for New Therapeutic Targets
Olav Engebraaten et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Francois Vaillant et al.
CANCER CELL (2013)
Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
Ming Qiu et al.
CANCER LETTERS (2013)
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
Xiaomei Zhang et al.
CANCER RESEARCH (2013)
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li et al.
CELL REPORTS (2013)
Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment
Clare L. Scott et al.
FRONTIERS IN ONCOLOGY (2013)
Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
Peter Kabos et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
Sylvia Julien et al.
CLINICAL CANCER RESEARCH (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Patient-Derived First Generation Xenografts of Non-Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy
Xin Dong et al.
CLINICAL CANCER RESEARCH (2010)
Local Regulation of Human Breast Xenograft Models
Jodie M. Fleming et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models
Huiping Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
Michael P. Kim et al.
NATURE PROTOCOLS (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging
Amin Hajitou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A new model of patient tumor-derived breast cancer Xenografts for preclinical assays
Elisabetta Marangoni et al.
CLINICAL CANCER RESEARCH (2007)
Humanized mice in translational biomedical research
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Triple-negative breast cancer: therapeutic options
Susan Cleator et al.
LANCET ONCOLOGY (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
